Application of autologous bone marrow mononuclear cells in six patients with advanced chronic critical limb ischemia as a result of diabetes: our experience

References

• Second European Consensus Document. Eur J Vasc Surg. 1992;6(Suppl A):1–32.
   Google Scholar
• Lipsky BA. Evidence based antibiotic therapy of diabetic foot infections. FEMS Immunol Med Microbiol. 1999;26: 267–76.
   PubMedGoogle Scholar
• Deresinski S. Infections in diabetic patients: strategies for clinicians. Infect Dis Rep. 1995;1:1–12.
   Google Scholar
• Ho TK, Rajkumar V, Ponticos M, Leoni P, Black DC, Abraham DJ, Baker DM. Increased endogenous angiogenic response and hypoxia-inducible factor-1alpha in human critical limb ischemia. J Vasc Surg. 2006;43:125–33.
   PubMedGoogle Scholar
• Losordo DW, Dimmeler S. Therapeutic angiogenesis and vasculogenesis for ischemic disease. I. Angiogenic cytokines. Circulation. 2004;109:2487–91.
   PubMed Web of Science ®Google Scholar
• Emmerich J. Current state and perspective on medical treatment of critical leg ischemia: gene and cell therapy. Int J Low Extrem Wounds. 2005;4:234–41.
   PubMedGoogle Scholar
• Carmeliet P. Angiogenesis in health and disease. Nat Med. 2003;9:653–60.
   PubMed Web of Science ®Google Scholar
• Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med. 2000;6:389–95.
   PubMed Web of Science ®Google Scholar
• Amann B, Lüdemann C, Ratei R, Schmidt-Lucke JA. Autologous bone-marrow stem cell transplantation for induction of arteriogenesis for limb salvage in critical limb ischaemia. Zentralbl Chir. 2009;134:298–304.
   PubMedGoogle Scholar
• Takeshita S, Zheng LP, Brogi E, Kearney M, Pu LQ, Bunting S, . Therapeutic angiogenesis: a single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest. 1994;93:662–70.
   PubMed Web of Science ®Google Scholar
• Esato K, Hamano K, Li TS, Furutani A, Seyama A, Takenaka H, Zempo N. Neovascularization induced by autologous bone marrow cell implantation in peripheral arterial disease. Cell Transplant. 2002;11:747–52,1189–93.
   PubMed Web of Science ®Google Scholar
• Higashi Y, Kimura M, Hara K, Noma K, Jitsuiki D, Nakagawa K, . Autologous bone-marrow mononuclear cell implantation improves endothelium-dependent vasodilatation in patients with limb ischemia. Circulation. 2004;109:1215–18.
   PubMed Web of Science ®Google Scholar
• Miyamoto M, Yasutake M, Takano H, Takagi H, Takagi G, Mizuno H, . Therapeutic angiogenesis by autologous bone marrow cell implantation for refractory chronic peripheral arterial disease using assessment of neovascularization by 99mTc-tetrofosmin (TF) perfusion scintigraphy. Cell Transplant. 2004;13:429–37.
   PubMedGoogle Scholar
• Nizankowski R, Petriczek T, Skotnicki A, Szczeklik A. The treatment of advanced chronic lower limb ischaemia with marrow stem cell autotransplantation. Kardiol Pol. 2005; 63:351–60.
   PubMedGoogle Scholar
• Durdu S, Akar AR, Arat M, Sancak T, Eren NT, Ozyurda U. Autologous bone-marrow mononuclear cell implantation for patients with Rutherford grade II–III thromboangiitis obliterans. J Vasc Surg. 2006;44:732–9.
   PubMedGoogle Scholar
• Bartsch T, Falke T, Brehm M, Zeus T, Kögler G, Wernet P, . Transplantation of autologous adult bone marrow stem cells in patients with severe peripheral arterial occlusion disease. Med Klin (Munich). 2006;101(Suppl 1):195–7.
   PubMedGoogle Scholar
• Kajiguchi M, Kondo T, Izawa H, Kobayashi M, Yamamoto K, Shintani S, . Safety and efficacy of autologous progenitor cell transplantation for therapeutic angiogenesis in patients with critical limb ischemia. Circ J. 2007;71:196–201.
   PubMed Web of Science ®Google Scholar
• Huang PP, Yang XF, Li SZ, Wen JC, Zhang Y, Han ZC. Randomized comparison of G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow-mononuclear cells for the treatment of patients with lower limb arteriosclerosis obliterans. Thromb Haemost. 2007;98:1335–42.
   PubMed Web of Science ®Google Scholar
• Hernández P, Cortina L, Artaza H, Pol N, Lam RM, Dorticós, . Autologous bone-marrow mononuclear cell implantation in patients with severe lower limb ischaemia: a comparison of using blood cell separator and Ficoll density gradient centrifugation. Atherosclerosis. 2007;194:e52–6.
   Google Scholar
• Gu YQ, Zhang J, Guo LR, Qi LX, Zhang SW, Xu J, . Transplantation of autologous bone marrow mononuclear cells for patients with lower limb ischemia. Chin Med J (Engl). 2008;121:963–7.
   PubMedGoogle Scholar
• Chochola M, Pytlík R, Kobylka P, Skalická L, Kideryová L, Beran S, . Autologous intra-arterial infusion of bone marrow mononuclear cells in patients with critical leg ischemia. Int Angiol. 2008;27:281–90.
   PubMed Web of Science ®Google Scholar
• Wester T, Jørgensen JJ, Stranden E, Sandbaek G, Tjønnfjord G, Bay D, . Treatment with autologous bone marrow mononuclear cells in patients with critical lower limb ischaemia. A pilot study. Scand J Surg. 2008;97:56–62.
   PubMedGoogle Scholar
• Van Tongeren RB, Hamming JF, Fibbe WE, Van Weel V, Frerichs SJ, Stiggelbout AM, . Intramuscular or combined intramuscular/intra-arterial administration of bone marrow mononuclear cells: a clinical trial in patients with advanced limb ischemia. J Cardiovasc Surg (Torino). 2008; 49:51–8.
   PubMed Web of Science ®Google Scholar
• De Vriese AS, Billiet J, Van Droogenbroeck J, Ghekiere J, De Letter JA. Autologous transplantation of bone marrow mononuclear cells for limb ischemia in a Caucasian population with atherosclerosis obliterans. J Intern Med. 2008;263:395–403.
   PubMedGoogle Scholar
• Amann B, Luedemann C, Ratei R, Schmidt-Lucke JA. Autologous bone marrow cell transplantation increases leg perfusion and reduces amputations in patients with advanced critical limb ischemia due to peripheral artery disease. Cell Transplant. 2009;18:371–80.
   PubMedGoogle Scholar
• Kawamura A, Horie T, Tsuda I, Ikeda A, Egawa H, Imamura E, . Prevention of limb amputation in patients with limbs ulcers by autologous peripheral blood mononuclear cell implantation. Ther Apher Dial. 2005;9:59–63.
   PubMed Web of Science ®Google Scholar
• Kawamura A, Horie T, Tsuda I, Abe Y, Yamada M, Egawa H, . Clinical study of therapeutic angiogenesis by autologous peripheral blood stem cell (PBSC) transplantation in 92 patients with critically ischemic limbs. J Artif Organs. 2006;9:226–33.
   PubMedGoogle Scholar
• Fontaine R, Kim M, Kieny R. [Surgical treatment of peripheral circulation disorders]. Helv Chir Acta. 1954;21: 499–533.
   PubMedGoogle Scholar
• Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–53.
   PubMed Web of Science ®Google Scholar
• Bild DE, Selby JV, Sinnock P, Browner WS, Braveman P, Showstack JA. Lower extremity amputation in people with diabetes. Epidemiology and prevention. Diabetes Care. 1989;12:24–31.
   PubMed Web of Science ®Google Scholar
• Inaba S, Egashira K, Komori K. Peripheral-blood or bone-marrow mononuclear cells for therapeutic angiogenesis? Lancet. 2002;360(9350):2083.
   PubMedGoogle Scholar
• Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H, . Therapeutic angiogenesis using cell transplantation (TACT) study investigators. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet. 2002;360:427–35.
   PubMed Web of Science ®Google Scholar
• Lawall H, Bramlage P, Amann B. Stem cell and progenitor cell therapy in peripheral artery disease. A critical appraisal. Thromb Haemost. 2010;103:696–709.
   PubMed Web of Science ®Google Scholar
• Hershey JC, Baskin EP, Glass JD, Hartman HA, Gilberto DB, Rogers IT, Cook JJ. Revascularization in the rabbit hindlimb: dissociation between capillary sprouting and arteriogenesis. Cardiovasc Res. 2001;49:618–25.
   PubMed Web of Science ®Google Scholar
• Chappell DC, Varner SE, Nerem RM, Medford RM, Alexander RW. Oscillatory shear stress stimulates adhesion molecule expression in cultured human endothelium. Circ Res. 1998;82:532–9.
   PubMed Web of Science ®Google Scholar
• Heil M, Ziegelhoeffer T, Mees B, Schaper W. A different outlook on the role of bone marrow stem cells in vascular growth: bone marrow delivers software not hardware. Circ Res. 2004;94:573–4.
   PubMed Web of Science ®Google Scholar
• Isner JM, Asahara T. Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization. J Clin Invest. 1999;103:1231–6.
   PubMed Web of Science ®Google Scholar
• Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, . Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275:964–7.
   PubMed Web of Science ®Google Scholar
• Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science. 1997;276:71–4.
   PubMed Web of Science ®Google Scholar
• Giulian D, Woodward J, Young DG, Krebs JF, Lachman LB. Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization. J Neurosci. 1988;8: 2485–90.
   PubMed Web of Science ®Google Scholar
• Leibovich SJ, Polverini PJ, Shepard HM, Wiseman DM, Shively V, Nuseir N. Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha. Nature. 1987; 329:630–2.
   PubMed Web of Science ®Google Scholar